News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Danny Burke: Clinicopathological Insights into Advanced Acral Melanoma – A Peruvian Perspective
Danny Burke/LinkedIn
May 17, 2025, 14:11

Danny Burke: Clinicopathological Insights into Advanced Acral Melanoma – A Peruvian Perspective

Danny Burke, CEO at Ecancer, shared a post on LinkedIn:

“Need to find out more about advanced acral melanoma in Peru? We’ve recently published a study exploring clinicopathological traits, treatment response and BRAF status in affected patients.
This further underlines our Journal’s commitment to increase research capacity in under-supported parts of the world.”

Title: Clinicopathological features, response patterns, outcomes for and BRAF status in patients with advanced acral melanoma: a preliminary Peruvian study

Journal: ecancermedicalscience

Authors: Denisse Castro, Brady Beltrán, Oscar Carnero, Mauricio Póstigo, Wilhelm Valdivia, Cinthia Figueroa, Manuel Leiva, Marco López, Virgilio E Failoc-Rojas

Read More Article.

Clinicopathological

More posts featuring Danny Burke on OncoDaily.

Brady Beltrán cancer Cinthia Figueroa Clinicopathological Trials Danny Burke Denisse Castro Manuel Leiva Marco López Mauricio Póstigo OncoDaily Oncology Oscar Carnero Virgilio E Failoc-Rojas Wilhelm Valdivia
Special Coverage
Blog
May 17, 2025, 14:11
Danny Burke: Clinicopathological Insights into Advanced Acral Melanoma - A Peruvian Perspective
Blog
May 17, 2025, 13:47
Rasha Aboelhassan: From screening to early diagnosis and treatments at ESMO Breast 2025
Insight
May 17, 2025, 12:46
Key Takeaways from ACS CAN’s 2025 National Forum on the Future of Healthcare
Blog
May 17, 2025, 12:40
Partha Basu: CanScreen5 Webinar Series Focuses on Improving Cancer Control Programs in the Asia-Pacific Region
Blog
May 17, 2025, 12:40
Petros Grivas Prepares for Annual BCAN Walk in Seattle
Blog
May 17, 2025, 12:34
U.S. FDA will Host Independent and Scientific Expert Panel Open to Public
Blog
May 17, 2025, 12:24
Mark Yarchoan: Recent Advances in Therapeutic Cancer Vaccines
Blog
May 17, 2025, 12:16
Luis Lara-Mejía: Early Resistance in ALK+ NSCLC Targeted with Alectinib and Bevacizumab Combo
Blog
May 17, 2025, 12:09
Oscar Arrieta: Alectinib Plus Bevacizumab as First-Line Treatment in ALK-Rearranged NSCLC
Blog
May 17, 2025, 11:55
Jordi Remon Highlights EORTC Lung Cancer Group’s Spring Meeting in Genova
Science
May 17, 2025, 11:48
Raffaele Colombo: The Therapeutic Window of Antibody-Drug Conjugates
Blog
May 17, 2025, 11:40
Sachin Jain: Dismantling Medicine’s White Wall of Silence